301 related articles for article (PubMed ID: 21881695)
1. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
Aalbers J
Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
[No Abstract] [Full Text] [Related]
2. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
3. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
[TBL] [Abstract][Full Text] [Related]
5. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
6. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
7. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Lane D; Lip GY
Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476
[No Abstract] [Full Text] [Related]
8. Stroke in heart failure: atrial fibrillation revisited?
Pullicino P; Homma S
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
[No Abstract] [Full Text] [Related]
9. Oral anticoagulation and stroke in atrial fibrillation.
Epstein EF; Natarajan I
N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
[No Abstract] [Full Text] [Related]
10. Atrial fibrillation and anticoagulation therapy: different race, different risk, and different management?
Vivas D; Olmos C; Vilacosta I
Circ J; 2011; 75(6):1314-5. PubMed ID: 21532184
[No Abstract] [Full Text] [Related]
11. Elevated international normalized ratio from vitamin K supplement discontinuation.
Miesner AR; Sullivan TS
Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
[TBL] [Abstract][Full Text] [Related]
12. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
[TBL] [Abstract][Full Text] [Related]
13. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
Robertson SL; Mayer JB; Guthmann R
J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
[No Abstract] [Full Text] [Related]
14. Oral anticoagulation and stroke in atrial fibrillation.
Boos CJ
N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674043
[No Abstract] [Full Text] [Related]
15. Dabigatran for stroke prevention in all patients with atrial fibrillation?
Hunchuck JE; Lake JD
Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
[No Abstract] [Full Text] [Related]
16. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
Yamamoto R; Nakae Y; Tanaka F; Johkura K
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
[TBL] [Abstract][Full Text] [Related]
17. Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.
Jackson SL; Peterson GM
J Clin Pharm Ther; 2011 Feb; 36(1):71-9. PubMed ID: 21198722
[TBL] [Abstract][Full Text] [Related]
18. Updated guidelines on outpatient anticoagulation.
Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
[TBL] [Abstract][Full Text] [Related]
19. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
20. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
Schulman S
N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
